elacridar has been researched along with entinostat in 2 studies
| Studies (elacridar) | Trials (elacridar) | Recent Studies (post-2010) (elacridar) | Studies (entinostat) | Trials (entinostat) | Recent Studies (post-2010) (entinostat) |
|---|---|---|---|---|---|
| 284 | 8 | 119 | 557 | 31 | 402 |
| Protein | Taxonomy | elacridar (IC50) | entinostat (IC50) |
|---|---|---|---|
| Histone deacetylase 3 | Homo sapiens (human) | 1.5547 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.73 | |
| Tissue factor | Homo sapiens (human) | 8 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 3.93 | |
| Histone deacetylase 4 | Homo sapiens (human) | 2.5077 | |
| Histone deacetylase 1 | Homo sapiens (human) | 1.0631 | |
| Histone deacetylase 7 | Homo sapiens (human) | 2.7679 | |
| Histone deacetylase 2 | Homo sapiens (human) | 1.4517 | |
| Polyamine deacetylase HDAC10 | Homo sapiens (human) | 3.1451 | |
| Histone deacetylase 11 | Homo sapiens (human) | 3.3762 | |
| Histone deacetylase 8 | Homo sapiens (human) | 3.5118 | |
| Histone deacetylase 6 | Homo sapiens (human) | 2.9645 | |
| Histone deacetylase 9 | Homo sapiens (human) | 2.9949 | |
| Histone deacetylase 5 | Homo sapiens (human) | 2.7109 | |
| Histone deacetylase | Plasmodium falciparum (malaria parasite P. falciparum) | 0.94 | |
| Nuclear receptor corepressor 2 | Homo sapiens (human) | 1.185 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
2 other study(ies) available for elacridar and entinostat
| Article | Year |
|---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |